🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SABCS Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp YaleBreastCancer Eric Winer, MD Ana Ferrigno Qin Yan, PhD Mariya Rozenblit @nainglinshan

So lucky to have such wonderful colleagues.

"Each person should feel empowered to think about cancer screening + prevention, discuss this with their doctors, and discuss with families." Veda Giri for #NationalCancerPreventionMonth Yale Cancer Center Yale School of Medicine Yale New Haven Hosp yalecancercenter.org/news-article/v…

A year-long lifestyle intervention for patients with #breastcancer undergoing chemotherapy resulted in ⬆️physical activity,  ⬇️ fatigue, ⬆️ strength training, and suggestive improvements in diet quality. #LEANer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Tara Sanft @mirwin_yale Leah Puklin

#ctDNA tests could identify pts w/ early-stage #BreastCancer who will experience recurrence. But w/ no evidence that ctDNA monitoring improves survival, clinical guidelines do not recommend testing. Read more in #ASCODailyNews: brnw.ch/21wIw2b Mariya Rozenblit Yale Cancer Center

Dr. Kim Blenman presents at #AACR24 poster session.

Published today, our review on #survivorship care for #young pts with #BreastCancer highlighting best practices for caring for #fertility #sexualhealth & #qualityoflife Maryam Lustberg MD, MPH, FASCO YaleBreastCancer Smilow Cancer Hospital Yale Surgery the breasties link.springer.com/article/10.100…

Our work on hospice referrals among patients with cancer was featured on Becker's Hospital Review - @ElizabethPrsic Smilow Hospitalist Service Smilow Cancer Hospital #Cancer #OncoDaily #Oncology #PatientCare #CancerResearch #Hospital oncodaily.com/47092.html

Out in npj Journals Breast: The proportion of pts with an actionable alteration (AA) in serial cfDNA⬇️with time AA in HR+/HER2- MBC inform the selection of 🎯therapies while cfDNA in TNBC or HER2+ MBC seems less effective in guiding treatment OncoAlert nature.com/articles/s4152…

Congratulations 🎉 Proud of Mariya Rozenblit Yale Cancer Center for being a part of this international effort #bcsm #globonc

With increase in early onset cancers, updated guidelines on how to optimize #survonc. Happy to contribute to this multi D Journal of the @NCCN #ayacsm panel Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology doi.org/10.6004/jnccn.…

So lucky to work with this wonderful team at Greenwich! Beautiful day to walk and support American Cancer Society Making Strides against Breast Cancer.

A multi-institutional cohort study found that breast cancer patients with TP53 pathogenic variants who underwent radiation therapy faced a significantly elevated risk (8.8%) of developing in-field sarcoma at 15 years compared to the general population. ja.ma/494i44f

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status out on JCO buff.ly/t1F2mzJ This international, multicenter, retrospective cohort study examined the clinical behavior of breast cancer in young BRCA1 and

If you are living with HER2+ oligometastatic breast cancer (oligo = limited # of mets) you may be eligible to participate in the CHLOE study Yale Cancer Center . Individuals (US & international) can now self refer! #bcsm Mariya Rozenblit Read more below: chloe.yalepathaws.org

“Invest where the impact begins”: Tremendous session at the BIG-NCTN annual meeting laying out a roadmap for how to nurture and support the next generation of cancer researchers. Dario Trapani Yara Abdou Mariya Rozenblit Ioannis Zerdes Seamus O’Reilly MD PhD Breast International Group

Honored to present at the Breast International Group - National Cancer Institute NCTN Annual Meeting in Chicago 🇺🇸, marking 20 years of global collaboration in #breastcancerresearch Many thanks to The Breast Cancer Research Foundation & Drs Seamus O’Reilly MD PhD Nancy Lin, MD Dario Trapani Yara Abdou, MD, MSCR Mariya Rozenblit for an inspiring session! OncoAlert

Congratulations to Mariya Rozenblit Yale School of Medicine

Congratulations to our faculty and fellows on their awards from Conquer Cancer, the ASCO Foundation at #ASCO25! (l-r) Mariya Rozenblit Amin Nassar, MD Nicole Casasanta Dr. Devora Isseroff & Dr. Benjamin Lu Learn more ⬇️ yalecancercenter.org/news-article/2… Yale Hematology Oncology Fellows Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp ASCO